Pfizer Vaccine Hopes Give Dow 800-Point Shot in the Arm

NEW YORK — U.S. stocks rallied Monday but closed well below session highs after drugmakers Pfizer and BioNTech announced preliminary “success” in trials of a COVID-19 vaccine candidate.

The Dow Jones Industrial Average closed with a gain of 834 points, or nearly 3%, at 29,157 but was up by as much as 1,600 points at the start of trading. 

While the benchmark index set a new intraday record and flirted with 30,000, momentum faded as the session went on. The broader S&P 500 index closed with a modest 1% gain.

Even so, the U.S. rally portends a higher open in Asian markets. Nikkei Stock Average futures rose in overnight trading on the Osaka Exchange. Read more…..

NinjaTrader-Download-Animated-728x90

Chart of the Day

Icarus TV

As Berkshire’s Vice Chairman, the 95-year-old Munger is Warren Buffett’s right-hand man. He’s also an investing legend in his own right. Munger ran a firm in the 1960s and ’70s that scored returns of over 24% per year. He’s here to talk about how to make investment decisions and life choices that help secure prosperity and longevity.

Share This Post

Leave a Reply